Meridian Bioscience Q2 Results Beat View; Reiterates FY17 Outlook

Meridian Bioscience Inc. (VIVO) reported a 2 percent increase in profit for the second quarter from last year on higher revenues.

from RTT - Earnings http://ift.tt/2p7f8Q3
via IFTTT